These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32107002)

  • 1. Management of metabolic syndrome and reduction in body weight in type II diabetic mice by inhibiting glycosphingolipid synthesis.
    Chatterjee S; Zheng L; Ma S; Bedja D; Bandaru VVR; Kim G; Rangecroft AB; Iocco D; Campbell SA
    Biochem Biophys Res Commun; 2020 Apr; 525(2):455-461. PubMed ID: 32107002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E-/- mice and rabbits fed a high-fat and -cholesterol diet.
    Chatterjee S; Bedja D; Mishra S; Amuzie C; Avolio A; Kass DA; Berkowitz D; Renehan M
    Circulation; 2014 Jun; 129(23):2403-13. PubMed ID: 24710030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agents for the treatment of glycosphingolipid storage disorders.
    Abe A; Wild SR; Lee WL; Shayman JA
    Curr Drug Metab; 2001 Sep; 2(3):331-8. PubMed ID: 11513334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
    Luo L; Fang K; Dan X; Gu M
    Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-/- mice.
    Mishra S; Bedja D; Amuzie C; Avolio A; Chatterjee S
    Biochem Biophys Res Commun; 2015 Sep; 465(1):159-64. PubMed ID: 26253472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice models.
    Anil TM; Harish C; Lakshmi MN; Harsha K; Onkaramurthy M; Sathish Kumar V; Shree N; Geetha V; Balamurali GV; Gopala AS; Madhusudhan Reddy B; Govind MK; Anup MO; Moolemath Y; Venkataranganna MV; Jagannath MR; Somesh BP
    Cardiovasc Diabetol; 2014 Jan; 13():27. PubMed ID: 24460834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of Nitraria retusa ethanolic extract enhances hepatic lipid metabolism in db/db mice model 'BKS.Cg-Dock7(m)+/+ Lepr(db/)J' through the modulation of lipogenesis-lipolysis balance.
    Zar Kalai F; Han J; Ksouri R; Abdelly C; Isoda H
    Food Chem Toxicol; 2014 Oct; 72():247-56. PubMed ID: 25086370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells.
    Kojima K; Shimada T; Nagareda Y; Watanabe M; Ishizaki J; Sai Y; Miyamoto K; Aburada M
    Biol Pharm Bull; 2011; 34(10):1613-8. PubMed ID: 21963504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel anti-diabetic effect of SCM-198 via inhibiting the hepatic NF-κB pathway in db/db mice.
    Huang H; Xin H; Liu X; Xu Y; Wen D; Zhang Y; Zhu YZ
    Biosci Rep; 2012 Apr; 32(2):185-95. PubMed ID: 21859425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice.
    Lim E; Lim JY; Kim E; Kim YS; Shin JH; Seok PR; Jung S; Yoo SH; Kim Y
    Nutrients; 2016 Dec; 8(12):. PubMed ID: 27929393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding.
    Kobayashi K; Forte TM; Taniguchi S; Ishida BY; Oka K; Chan L
    Metabolism; 2000 Jan; 49(1):22-31. PubMed ID: 10647060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-obesity effects of boiled tuna extract in mice with obesity induced by a high-fat diet.
    Kim Y; Kwon MJ; Choi JW; Lee MK; Kim C; Jung J; Aprianita H; Nam H; Nam TJ
    Int J Mol Med; 2016 Oct; 38(4):1281-8. PubMed ID: 27498820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.
    Sedeek M; Gutsol A; Montezano AC; Burger D; Nguyen Dinh Cat A; Kennedy CR; Burns KD; Cooper ME; Jandeleit-Dahm K; Page P; Szyndralewiez C; Heitz F; Hebert RL; Touyz RM
    Clin Sci (Lond); 2013 Feb; 124(3):191-202. PubMed ID: 22920224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice.
    Dhanesha N; Joharapurkar A; Shah G; Kshirsagar S; Dhote V; Sharma A; Jain M
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):69-77. PubMed ID: 22060140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term inhibition of miR-21 leads to reduction of obesity in db/db mice.
    Seeger T; Fischer A; Muhly-Reinholz M; Zeiher AM; Dimmeler S
    Obesity (Silver Spring); 2014 Nov; 22(11):2352-60. PubMed ID: 25141837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of buckwheat sprouts on plasma and hepatic parameters in type 2 diabetic db/db mice.
    Watanabe M; Ayugase J
    J Food Sci; 2010; 75(9):H294-9. PubMed ID: 21535603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glycosphingolipid synthesis by threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and the modulation of IL-1beta-stimulated expression of inducible nitric oxide synthase in rat aortic smooth muscle cells.
    Weber AA; Seul C; Harth V; Ko Y; Seewald S; Vetter H; Sachinidis A
    Br J Pharmacol; 1998 Mar; 123(5):906-10. PubMed ID: 9535019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.